Related Experiment Video
Updated: Apr 18, 2026
Bottom-up and Shotgun Proteomics to Identify a Comprehensive Cochlear Proteome
Published on: March 7, 2014
Identification of target proteins involved in cochlear otosclerosis
Céline Richard1, Joni K Doherty, Jose N Fayad
1*Otorhinolaryngology Department, Hôpital Nord-Ouest, Villefranche-sur-Saône, France; †Shohet Ear Associates Medical Group, Seal Beach, California; ‡House Clinic, Los Angeles, California; §House Temporal Bone Laboratory, University of California, Los Angeles, California, U.S.A.
Hypothesis:
Investigation of differential protein expression will provide clues to pathophysiology in otosclerosis.
Background:
Otosclerosis is a bone remodeling disorder limited to the endochondral layer of the otic capsule within the temporal bone. Some authors have suggested an inflammatory etiology for otosclerosis resulting from persistent measles virus infection involving the otic capsule. Despite numerous genetic studies, implication of candidate genes in the otosclerotic process remains elusive. We employed liquid chromatography-mass spectrometry (LC-MS) analysis on formalin-fixed celloidin-embedded temporal bone tissues for postmortem investigation of otosclerosis.
Methods:
Proteomic analysis was performed using human temporal bones from a patient with severe otosclerosis and a control temporal bone. Sections were dissected under microscopy to remove otosclerotic lesions and normal otic capsule for proteomic analysis. Tandem 2D chromatography mass spectrometry was employed. Data analysis and peptide matching to FASTA human databases was done using SEQUEST and proteome discoverer software.
Results:
TGFβ1 was identified in otosclerosis but not in the normal control temporal bone specimen. Aside from TGFβ1, many proteins and predicted cDNA-encoded proteins were observed, with implications in cell death and/or proliferation pathways, suggesting a possible role in otosclerotic bone remodeling. Immunostaining using TGFβ1 monoclonal revealed marked staining of the spongiotic otosclerotic lesions.
Conclusions:
Mechanisms involved in cochlear extension of otosclerosis are still unclear, but the implication of TGFβ1 is supported by the present proteomic data and immunostaining results. The established role of TGFβ1 in the chondrogenesis process supports the theory of a reaction targeting the globulae interossei within the otic capsule.
Insights
This study identified TGFβ1 in otosclerosis temporal bone samples, suggesting its role in the bone remodeling disorder. Further research into TGFβ1 mechanisms could clarify otosclerosis pathophysiology.
Area of Science:
- Otopathology
- Molecular Biology
- Proteomics
Background:
- Otosclerosis is a bone remodeling disorder of the temporal bone's otic capsule.
- An inflammatory etiology, possibly linked to measles virus, has been proposed for otosclerosis.
- Genetic studies have yet to definitively identify causative genes for otosclerosis.
Purpose of the Study:
- To investigate differential protein expression in otosclerosis using proteomic analysis.
- To identify proteins involved in the pathophysiology of otosclerosis.
- To explore the potential role of specific proteins in otosclerotic bone remodeling.
Main Methods:
- Proteomic analysis of human temporal bones from an otosclerosis patient and a control.
- Liquid chromatography-mass spectrometry (LC-MS) on formalin-fixed, celloidin-embedded tissues.
- Tandem 2D chromatography mass spectrometry with SEQUEST and proteome discoverer software for data analysis.
Main Results:
- Transforming Growth Factor beta 1 (TGFβ1) was identified in otosclerosis but not in control specimens.
- Proteins implicated in cell death and proliferation pathways were observed, suggesting a role in bone remodeling.
- Immunostaining confirmed marked TGFβ1 presence in otosclerotic lesions.
Conclusions:
- The protein TGFβ1 is implicated in otosclerosis pathophysiology, supported by proteomic and immunostaining data.
- TGFβ1's role in chondrogenesis suggests a potential mechanism in otosclerotic bone remodeling.
- Further investigation into TGFβ1 may elucidate the mechanisms of cochlear otosclerosis extension.
